Cost-Effectiveness of a Web-Based Interactive Therapeutic Education Platform: Evidence From a Randomized Clinical Trial for Patients With End-Stage Renal Disease
Author(s)
Pillebout E1, Rochaix L2, Perrier L3, Haon B4, Diop M5, Durand Zaleski I6
1AP-HP, Paris, Île-de-France, France, 2Hospinnomics, Paris, France, 3GATE Lyon Saint-Etienne, Lyon, France, 4Paris School of Economics, Paris, France, 5university of Granada, Granada, GR, Spain, 6ECEVE UMR 1123, CRETEIL, France
Presentation Documents
OBJECTIVES: End-Stage Renal disease (ESRD) affected 89,692 patients in France in 2018, with a cost estimate of €4.2 billion. Education about their disease empowers patients and allows improved disease management and better health outcomes. This study explores whether providing access to an interactive web-based patient education platform is cost-effective.
METHODS: The CEA was designed as part of a multicenter, prospective clinical trial. ESRD or post-transplant patients were randomized 1:1:1 in i) a control group with no specific therapeutic patient education (TPE) program (control); ii) an intervention group with online TPE (e-TPE); iii) an intervention group with online TPE coupled with community features such as a patient forum and a chat-room with both patients and health care professionals (e-TPE+chat). Hospital costs (€ 2022) were assessed from the French health insurance perspective with an 18 months’ time horizon. Patients’ expenditures were retrieved from hospital-based information. Costs included the provision of e-TPE under the two intervention groups. The QALYs were derived from EQ5D-5L scores. Probabilistic analyses were performed.
RESULTS: Contrary to expectations, 45% of patients in both intervention groups stated that they never used the e-TPE platform. Total mean costs were respectively €2,025 (SD: 5,949), €3,089 (SD: 4,976), €3,154 (SD: 6,428) for groups i) to iii), and mean QALYs were €1,336 (SD: 0.163), €1,352 (SD: 0.169) and €1,328 (SD: 0.215). e-TPE was more effective but more expensive compared to the control group (ICER: €66,053 per QALY). The probability of e-TPE being cost-effective was 50% for a willingness to pay of €75,000. Results do not show a dominance of e-TPE+chat on e-TPE.
CONCLUSIONS: The e-TPE + chat group differs from the e-TPE group essentially in the operating costs of the community features. Further research will complement existing results using EQ-5D by relying on additional information collected on patient welfare using ICECAP-A and behavioral traits.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Code
EE267
Topic
Economic Evaluation, Medical Technologies
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis, Trial-Based Economic Evaluation
Disease
Urinary/Kidney Disorders